Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,138,270
-$6,555,298 QoQ
Shares Held
246,282
+1.0% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#67
of 780 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ALNY ranks #13 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,138,270 | 246,282 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $80,693,568 | 243,883 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $699,466 | 1,759 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $41,856,696 | 91,791 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $203,191,570 | 623,115 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,248,409 | 156,464 | Shares | Sole | 2025-05-15 | |
| 2022-12-31 | $22,592,910 | 95,068 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||